Navigation Links
BioClinica, Inc. to Demonstrate Technology-Enhanced Capabilities at Upcoming Global Industry Events
Date:4/3/2013

– 24, 2013
Santa Anna Pueblo, New Mexico
Booth #21
The GCSG conference is the most comprehensive conference in the clinical supply chain arena, offering an open forum for sharing knowledge and best practices for clinical supply and related professionals. BioClinica representatives will be on hand to demonstrate the company's suite of clinical trial services that maximize efficiency and manageability of the clinical trial process.

Nick Lenares , Chief Product Architect, will demonstrate BioClinica's Clinical Supply Optimizer solution during workshop six on April 23 at 2:00 pm. 

ShareFEST 2013 
April 25, 2013
Philadelphia, Pennsylvania 
Booth #16
ShareFEST is the premier SharePoint conference for life sciences, attended by senior business and IT professionals from over 120 pharmaceutical companies, device manufacturers, biotechs, and service providers. This year's conference will focus on the topic "Compliance Strategies for the Global Enterprise" with sessions on building global compliance solutions, scaling to address enterprise needs, and managing and leveraging SharePoint technology. Representatives from BioClinica will attend the conference and will be on hand to demonstrate OnPoint, our Microsoft Office-Smart Clinical Trial Management System.

Using BioClinica's OnPoint CTMS as a demonstration platform, eClinical Solutions Specialist and CTMS expert Jeremiah Rehm will present on the topic of CTMS and eTMF integration.

2013 Drug Information Association (DIA) China Annual Meeting 
May 12, 2013
Beijing, China 
Booth #B2 
The 5th DIA China Annual Meeting is the largest meeting held by DIA in the Asia and Pacific region. The meeting provides a neutral platform for information excha
'/>"/>

SOURCE BioClinica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
3. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
4. PLC to Demonstrate RenalGuard® at EuroPCR 2012
5. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
6. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
7. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
8. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
9. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
10. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
11. Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Ga., March 4, 2015  Halyard Health, Inc. (NYSE: ... and provided its 2015 outlook and related key planning ... Halyard Health as we report our fourth quarter results, ... Chairman and CEO. "We executed a smooth separation from ... the spin-off. We delivered sales growth and margin improvement ...
(Date:3/4/2015)... BOSTON , March 4, 2015   InspireMD, ... leader in embolic protection systems ("EPS"), today announced that ... up to approximately 34 million shares of common stock ... shares of common stock in a public offering.  The ... price of $0.40 per share, and each purchaser will ...
(Date:3/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming 27 th Annual ROTH ... Dana Point, CA.  Dr. Michael Berelowitz ... will present a corporate overview on March 10, 2015. ...
Breaking Medicine Technology:Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3
... SIRO Clinpharm, a leading full service Clinical Research Organization ... SIRO has developed a long term plan to align with ... charter is to transform SIRO into a global leader in ... continuing to build and enhance the biopharma service catalog for ...
... 2012  Amgen Inc. ("Amgen") (NASDAQ: AMGN ) announced ... tender offer (the "Offer") by a wholly owned subsidiary, "Merger ... Micromet, Inc. ("Micromet") (NASDAQ: MITI ) for $11.00 ... 12:00 midnight, New York City time, at the end of ...
Cached Medicine Technology:SIRO Clinpharm Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 4
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
(Date:3/4/2015)... March 04, 2015 The popular all-natural ... their new L-Style Revolution™ Program. The customized program provides ... women of all health and fitness levels to follow ... faster than traditional methods. , “We’re really proud to ... plans based on award winning techniques to help people ...
(Date:3/4/2015)... March 04, 2015 Columbus is no stranger ... prevalence of cocaine addiction, and suffers from the potential ... on Feb. 27th, the DEA revealed that Kratom is a ... herbal tea; the newly introduced herb from Southeast Asia acts ... heightened doses. WKYC notes kratom foments symptoms similar to heroin ...
(Date:3/4/2015)... Vancouver, BC (PRWEB) March 04, 2015 ... Research , millions of people in the U.S. suffer ... acid reflux. Medications are commonly prescribed to control acid ... invasive surgical procedures can overly correct the problem and ... A Market Opportunity, GERD occurs when the lower esophageal ...
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and co-host ... of the print publication. Mai embraces the overall theme of ... for clothes and personal care products. In an exclusive interview, ... to an organic diet. She mentions, “Having an organic lifestyle ... but also now as I’m a full time student at ...
Breaking Medicine News(10 mins):Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3
... Today, SOUTH SAN FRANCISCO, Calif., Feb. 28 Cell,Genesys, ... the,fourth quarter and full year ended December 31, 2007. The ... diluted share), for the fourth,quarter of 2007, compared to a ... the corresponding period in 2006. The net loss for the,year ...
... MOUNTAIN VIEW, Calif., Feb. 28 MAP,Pharmaceuticals, Inc. (Nasdaq: ... quarter and year ended December 31, 2007., The ... December 31, 2007,was $14.9 million and $40.1 million, respectively, ... periods in 2006. MAP,Pharmaceuticals had cash, cash equivalents and ...
... Feb. 28 Closer,analysis of the patent office "non-final" ... the Wisconsin Alumni Research Foundation (WARF),shows the following gains ... was abandoned showing it was underserved,and new amended claims ... all embryonic stem cells no matter how,they are derived, ...
... 28, 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced ... Forbes Holdings Inc., has made a $50 million gift ... NewYork-Presbyterian Hospital and Weill Cornell Medical College, in support ... the world. The gift will establish the Ronald O. ...
... COLUMBIA, Mo. University of Missouri scientist Kattesh ... using gold salts, soybeans and water. Kattis research ... could have major applications in several disciplines. , ... small they cannot be seen by the naked ...
... YORK, February 28 Ten prominent journalists from the ... for the fourth annual TempletonCambridge Journalism Fellowships in Science ... 2004, the fellowships include a program of research and ... The 2008 fellows were announced today by the New ...
Cached Medicine News:Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 2Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 3Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 4Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 5Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 7Health News:Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 3Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 4Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 5Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 2Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 4
The Biomet® CHS is indicated for intertrochanteric, subtrochanteric and basilar neck fractures of the proximal femur....
... procedures. Part of the osi modular ... top provides a complete, powered, orthopedic ... provides for skin or skeletal traction ... femur, supine or lateral im nailing; ...
... ElectroMagnetic Field (PEMF) bone growth stimulation delivered ... for long bone and small bone nonunions. ... orthopedic brace, or clothing without lessening its ... one compact, lightweight unit including success rates ...
Guardsman Femoral Interference Screw is specifically designed for endoscopic femoral fixation where graft protection is needed....
Medicine Products: